[
  {
    "ts": null,
    "headline": "Medtronic Announces Separation From Diabetes Business, CEO Says it’s “In a Really Good Spot”",
    "summary": "On Wednesday, Medtronic (NYSE:MDT) announced its intention to separate its diabetes business into a new, standalone company, to enhance focus on high-margin growth drivers for Medtronic and accelerate innovation for the new entity. The diabetes unit, which manufactures insulin pumps and other wearable devices, has recently returned to growth after struggling for several years due […]",
    "url": "https://finnhub.io/api/news?id=9773f38de8f61e0da37fea2ad2cad3620588205a7ab6d5c369e2de6a74b7bd00",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747950116,
      "headline": "Medtronic Announces Separation From Diabetes Business, CEO Says it’s “In a Really Good Spot”",
      "id": 134658756,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "On Wednesday, Medtronic (NYSE:MDT) announced its intention to separate its diabetes business into a new, standalone company, to enhance focus on high-margin growth drivers for Medtronic and accelerate innovation for the new entity. The diabetes unit, which manufactures insulin pumps and other wearable devices, has recently returned to growth after struggling for several years due […]",
      "url": "https://finnhub.io/api/news?id=9773f38de8f61e0da37fea2ad2cad3620588205a7ab6d5c369e2de6a74b7bd00"
    }
  },
  {
    "ts": null,
    "headline": "TD Cowen Keeps a Buy on Medtronic (MDT) After Better Growth in Q4",
    "summary": "Josh Jennings, an analyst from TD Cowen, reiterated a Buy rating on Medtronic plc (NYSE:MDT) with an unchanged price target of $95. The analyst viewed FQ4 2025 results favourably as the company managed to post an organic sales growth of 5.4%, ahead of street expectations of 4.6%. The analyst highlighted the strength of Medtronic’s strategy […]",
    "url": "https://finnhub.io/api/news?id=816d520310d9b2e075efc9079e29d5734da7cec0c2e50a17def993c33e1ea8f9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747947307,
      "headline": "TD Cowen Keeps a Buy on Medtronic (MDT) After Better Growth in Q4",
      "id": 134658757,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "Josh Jennings, an analyst from TD Cowen, reiterated a Buy rating on Medtronic plc (NYSE:MDT) with an unchanged price target of $95. The analyst viewed FQ4 2025 results favourably as the company managed to post an organic sales growth of 5.4%, ahead of street expectations of 4.6%. The analyst highlighted the strength of Medtronic’s strategy […]",
      "url": "https://finnhub.io/api/news?id=816d520310d9b2e075efc9079e29d5734da7cec0c2e50a17def993c33e1ea8f9"
    }
  },
  {
    "ts": null,
    "headline": "Abbott vs. Medtronic: Which Dividend-Paying MedTech Stock is Better?",
    "summary": "With both MDT & ABT focusing on their core strengths, the stage is set for a compelling comparison. Let's see which stock is poised for greater upside.",
    "url": "https://finnhub.io/api/news?id=c3fda8bfe3b991d6d994eea8a099fcf881ed7f5a8f8583d843f3f28c08d8ac0b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747940400,
      "headline": "Abbott vs. Medtronic: Which Dividend-Paying MedTech Stock is Better?",
      "id": 134658521,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "With both MDT & ABT focusing on their core strengths, the stage is set for a compelling comparison. Let's see which stock is poised for greater upside.",
      "url": "https://finnhub.io/api/news?id=c3fda8bfe3b991d6d994eea8a099fcf881ed7f5a8f8583d843f3f28c08d8ac0b"
    }
  },
  {
    "ts": null,
    "headline": "Medtronic PLC stock underperforms Thursday when compared to competitors",
    "summary": "Medtronic PLC stock underperforms Thursday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=529ffadac3b6d0b2f1dd65d15ef5162fd32259ec7b1a0ae121236b5dfa4a60c4",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747931400,
      "headline": "Medtronic PLC stock underperforms Thursday when compared to competitors",
      "id": 134665606,
      "image": "",
      "related": "MDT",
      "source": "MarketWatch",
      "summary": "Medtronic PLC stock underperforms Thursday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=529ffadac3b6d0b2f1dd65d15ef5162fd32259ec7b1a0ae121236b5dfa4a60c4"
    }
  },
  {
    "ts": null,
    "headline": "Medtronic Cardiovascular Strength Drives Fiscal Q4 Beat, RBC Says",
    "summary": "Medtronic (MDT) delivered modest beats on revenue and earnings in fiscal Q4, helped by broad-based s",
    "url": "https://finnhub.io/api/news?id=862fc61bbf06237e271ec84a973ff18e4ab390e2d2f035d63161c8f524bf4c47",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747925833,
      "headline": "Medtronic Cardiovascular Strength Drives Fiscal Q4 Beat, RBC Says",
      "id": 134658759,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "Medtronic (MDT) delivered modest beats on revenue and earnings in fiscal Q4, helped by broad-based s",
      "url": "https://finnhub.io/api/news?id=862fc61bbf06237e271ec84a973ff18e4ab390e2d2f035d63161c8f524bf4c47"
    }
  },
  {
    "ts": null,
    "headline": "BNY Mellon Global Equity Income Fund Q1 2025 Commentary",
    "summary": "BNY Mellon Global Equity Income Fund Q1 2025 Commentary",
    "url": "https://finnhub.io/api/news?id=21122177dcf301c8a85b28db74c633dac60cf5d385c12b4c38dab38f5f17dfc1",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747917060,
      "headline": "BNY Mellon Global Equity Income Fund Q1 2025 Commentary",
      "id": 134651954,
      "image": "",
      "related": "MDT",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=21122177dcf301c8a85b28db74c633dac60cf5d385c12b4c38dab38f5f17dfc1"
    }
  },
  {
    "ts": null,
    "headline": "Medtronic to split diabetes business into separate entity, targets IPO",
    "summary": "Medtronic anticipates the separation of its diabetes business unit into a wholly separate entity to complete within 18 months.",
    "url": "https://finnhub.io/api/news?id=784eba2ba76d7d9eceb98167fc2a94ed2300851c53d38d10e52dccd99bfc21f2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747915505,
      "headline": "Medtronic to split diabetes business into separate entity, targets IPO",
      "id": 134658760,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "Medtronic anticipates the separation of its diabetes business unit into a wholly separate entity to complete within 18 months.",
      "url": "https://finnhub.io/api/news?id=784eba2ba76d7d9eceb98167fc2a94ed2300851c53d38d10e52dccd99bfc21f2"
    }
  },
  {
    "ts": null,
    "headline": "BNY Mellon Dynamic Value Fund Q1 2025 Commentary",
    "summary": "BNY Mellon Dynamic Value Fund (Class A at NAV) returned 2.63% during the first quarter of 2025.",
    "url": "https://finnhub.io/api/news?id=dffb1eabb98f7e0a46b4ce50bd2a55265d5a39faf2464cfe0fc9beea9f4d2017",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747912440,
      "headline": "BNY Mellon Dynamic Value Fund Q1 2025 Commentary",
      "id": 134651348,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2160994971/image_2160994971.jpg?io=getty-c-w1536",
      "related": "MDT",
      "source": "SeekingAlpha",
      "summary": "BNY Mellon Dynamic Value Fund (Class A at NAV) returned 2.63% during the first quarter of 2025.",
      "url": "https://finnhub.io/api/news?id=dffb1eabb98f7e0a46b4ce50bd2a55265d5a39faf2464cfe0fc9beea9f4d2017"
    }
  },
  {
    "ts": null,
    "headline": "Medtronic reports strong finish to its fiscal year with its fourth quarter financial results, announces dividend increase",
    "summary": "GALWAY, Ireland - Medtronic plc , a global leader in healthcare technology, announced financial results for its fourth quarter and fiscal year 2025 , which ended April 25, 2025.Q4 Key HighlightsQ4...",
    "url": "https://finnhub.io/api/news?id=d8971e254a9772966c0a1bb48262015980be1438b8603e567dec9002259efea4",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747911387,
      "headline": "Medtronic reports strong finish to its fiscal year with its fourth quarter financial results, announces dividend increase",
      "id": 134651032,
      "image": "",
      "related": "MDT",
      "source": "Finnhub",
      "summary": "GALWAY, Ireland - Medtronic plc , a global leader in healthcare technology, announced financial results for its fourth quarter and fiscal year 2025 , which ended April 25, 2025.Q4 Key HighlightsQ4...",
      "url": "https://finnhub.io/api/news?id=d8971e254a9772966c0a1bb48262015980be1438b8603e567dec9002259efea4"
    }
  },
  {
    "ts": null,
    "headline": "Why Medtronic plans to spin out its diabetes business",
    "summary": "While some analysts questioned why Medtronic would leave a fast-growing market, others backed the company’s plan to focus on segments with higher margins.",
    "url": "https://finnhub.io/api/news?id=f4ace76affa9db416e3099542bb63f740c797a2a4531bff5f03111129e922bb2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747908307,
      "headline": "Why Medtronic plans to spin out its diabetes business",
      "id": 134658761,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "While some analysts questioned why Medtronic would leave a fast-growing market, others backed the company’s plan to focus on segments with higher margins.",
      "url": "https://finnhub.io/api/news?id=f4ace76affa9db416e3099542bb63f740c797a2a4531bff5f03111129e922bb2"
    }
  },
  {
    "ts": null,
    "headline": "Medtronic PLC (MDT) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Moves",
    "summary": "Medtronic PLC (MDT) reports robust organic growth and strategic initiatives, including a Diabetes business spin-off, to enhance profitability and focus on high-margin markets.",
    "url": "https://finnhub.io/api/news?id=3fecc2a650bc596e1787c0c62d58cdb190886c278492e58e259ead3e47f3a1bf",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747897411,
      "headline": "Medtronic PLC (MDT) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Moves",
      "id": 134648070,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "Medtronic PLC (MDT) reports robust organic growth and strategic initiatives, including a Diabetes business spin-off, to enhance profitability and focus on high-margin markets.",
      "url": "https://finnhub.io/api/news?id=3fecc2a650bc596e1787c0c62d58cdb190886c278492e58e259ead3e47f3a1bf"
    }
  },
  {
    "ts": null,
    "headline": "Medtronic still hiding behind its status as a dividend aristocrat",
    "summary": "The world leader in medical equipment is a master in the art of making announcements; in the absence of objective economic performance, it certainly knows how to appease its shareholders.",
    "url": "https://finnhub.io/api/news?id=eec91fcbca7c9045c4757ca9ad9a217520afc29f80d746169e83f76d2fab8bad",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747887892,
      "headline": "Medtronic still hiding behind its status as a dividend aristocrat",
      "id": 134644499,
      "image": "",
      "related": "MDT",
      "source": "Finnhub",
      "summary": "The world leader in medical equipment is a master in the art of making announcements; in the absence of objective economic performance, it certainly knows how to appease its shareholders.",
      "url": "https://finnhub.io/api/news?id=eec91fcbca7c9045c4757ca9ad9a217520afc29f80d746169e83f76d2fab8bad"
    }
  },
  {
    "ts": null,
    "headline": "Medtronic : expands its Acute Care & Monitoring portfolio in Europe with a new distribution agreement for the Corsano™ multi-parameter wearable",
    "summary": "The medically-certified multi-parameter wearable designed for continuous monitoring of vital signs enhances the Medtronic portfolio of patient monitoring solutions. [...]This is an abstract of the...",
    "url": "https://finnhub.io/api/news?id=c32af05450b9af3b2cf81da2852262bdc68350c8ef0d58d009409936e096f269",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747884008,
      "headline": "Medtronic : expands its Acute Care & Monitoring portfolio in Europe with a new distribution agreement for the Corsano™ multi-parameter wearable",
      "id": 134640323,
      "image": "",
      "related": "MDT",
      "source": "Finnhub",
      "summary": "The medically-certified multi-parameter wearable designed for continuous monitoring of vital signs enhances the Medtronic portfolio of patient monitoring solutions. [...]This is an abstract of the...",
      "url": "https://finnhub.io/api/news?id=c32af05450b9af3b2cf81da2852262bdc68350c8ef0d58d009409936e096f269"
    }
  }
]